Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up

Digestive and Liver Disease

Volumn 43, Issue 4, 2011, Pages 295-299

  Vannella, Lucy ^a   Lahner, Edith ^a   Bordi, Cesare ^b   Pilozzi, Emanuela ^a   Di Giulio, Emilio ^a   Corleto, Vito D ^a   Osborn, John ^c   Delle Fave, Gianfranco ^a   Annibale, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atrophic body gastritis; H. pylori infection; Intestinal metaplasia

Indexed keywords

BISMUTH; CELL ANTIBODY; COBALAMIN; GASTRIN; HEMOGLOBIN; PEPSINOGEN I;

ADULT; AGED; ARTICLE; ATROPHIC BODY GASTRITIS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; ERADICATION THERAPY; ERYTHROCYTE VOLUME; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTRITIS; GASTROSCOPY; GIEMSA STAIN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERNICIOUS ANEMIA; PREDICTION; PRIORITY JOURNAL; REVERSAL REACTION; SEROLOGY; SMOKING HABIT; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH PARIETAL CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, PERNICIOUS; ANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PARIETAL CELLS, GASTRIC; PEPSINOGEN A; PROPORTIONAL HAZARDS MODELS; PYLORIC ANTRUM; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79952195659     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.10.012     Document Type: Article

References (27)

1. Lee E.L., Feldman M. Gastritis and other gastropathies. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management 2002, 810-827. WB Saunders, Philadelphia, USA. 7th ed. M. Feldman, L.S. Friedman, M.H. Sleisenger (Eds.).
2. Sipponen P., Kekki M., Seppälä K., et al. The relationships between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther 1996, 10:103-118.
3. Waring A.J., Drake I.M., Schorah C.J., et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996, 38:171-176.
4. Witteman E.M., Mravunac M., Becx M.J., et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol 1995, 48:250-256.
5. Sung J.J., Lin S.R., Ching J.Y., et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000, 119:7-14.
6. Lu B., Chen M.T., Fan Y.H., et al. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. World J Gastroenterol 2005, 11:6518-6520.
7. Tucci A., Poli L., Tosetti C., et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998, 93:1425-1431.
8. Ruiz B., Garay J., Correa P., et al. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001, 96:3281-3287.
9. Zhou L., Sung J.J., Lin S., et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl) 2003, 116:11-14.
10. Morales T.G., Sampliner R.E., Camargo E., et al. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication. J Clin Gastroenterol 2001, 32:400-404.
11. Satoh K., Kimura K., Takimoto T., et al. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998, 3:236-240.
12. Van der Hulst R.W., van der Ende A., Dekker F.W., et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997, 113:25-30.
13. Ito M., Haruma K., Kamada T., et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002, 16:1449-1456.
14. Ohkusa T., Fujiki K., Takashimizu I., et al. Improvement in Atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001, 134:380-386.
15. Rokkas T., Pistiolas D., Sechopoulos P., et al. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007, 12(Suppl. 2):32-38.
16. Marignani M., Delle Fave G., Mecarocci S., et al. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am J Gastroenterol 1999, 94:766-772.
17. Annibale B., Marignani M., Azzoni C., et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter. 1997, 2:57-64.
18. Lahner E., Caruana P., D'Ambra G., et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done?. Gastrointest Endosc 2001, 53:443-448.
19. Lahner E., Bordi C., Di Giulio E., et al. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther 2002, 16:507-514.
20. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
21. Yamada T., Miwa H., Fujino T. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J Clin Gastroenterol 2003, 36:405-410.
22. Lahner E., Bordi C., Cattaruzza M.S., et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther 2005, 22:471-481.
23. Kuipers E.J., Nelis G.F., Klinkenberg-Knol E.C., et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004, 53:12-20.
24. Mera R., Fontham E.T., Bravo L.E., et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005, 54:1536-1540.
25. Dixon M.F. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001, 49:2-4.
26. Annibale B., Di Giulio E, Caruana P., et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002, 16:1723-1731.
27. Genta R.M., Rugge M. Gastric precancerous lesions: heading for an international consensus. Gut 1999, 45(Suppl. I):15-18.